The rating assignment is based on several factors, including McLaren’s leading market share in its primary service area.
The outlook is stable.
Fitch also affirmed the “AA-” rating on McLaren’s $495 million of bonds and withdrew the “AA-” rating on McLaren’s series 2008A bonds.
More articles on healthcare finance:
CMS: ACA policyholders’ out-of-pocket costs declined this year
Moody’s: 5 mid-year updates on 2016’s top healthcare issues
Risk and rewards of shared savings contracts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
